                            UNITED STATES DISTRICT COURT
                            FOR THE DISTRICT OF COLUMBIA

PALETERIA LA MICHOACANA, INC. et al., :
                                            :
           Plaintiffs & Counter-Defendants, :            Civil Action No.:      11-1623 (RC)
                                            :
           v.                               :            Re Document Nos.:      70, 72, 75
                                            :
PRODUCTOS LACTEOS TOCUMBO S.A.              :
DE C.V.,                                    :
                                            :
           Defendant & Counter-Claimant. :

                                 MEMORANDUM OPINION

                 DENYING PROLACTO’S MOTION FOR A PROTECTIVE ORDER;
                       GRANTING PROLACTO’S MOTION TO SEAL;
                  OVERRULING AS MOOT PLM’S OBJECTIONS TO EVIDENCE


                                      I. INTRODUCTION

       The parties in this matter claim the exclusive right to use various trademarks in

connection with the sale of their food products, including ice cream and fruit popsicles, in the

United States. The defendant and counter-claimant now seeks a protective order requiring that

the deposition of its corporate designees take place in or near Mexico City, Mexico.

Alternatively, the defendant and counter-claimant seeks an order requiring that the plaintiffs and

counter-defendants pay for the corporate designees’ travel, lodging, and per diem expenses if the

deposition goes forward in the United States. Because the defendant and counter-claimant has

not shown that deposition of its corporate designees in the United States will be unduly

burdensome, the Court will deny its motion.
                                II. FACTUAL BACKGROUND

       The plaintiffs and counter-defendants, Paleteria La Michoacana, Inc. and Paleteria La

Michoacana, LLC (collectively, “PLM”), are closely related companies that produce and

distribute ice cream bars known as “paletas.” The defendant and counter-claimant, Productos

Lacteos Tocumbo S.A. de C.V. (“Prolacto”), is a Mexican company that operates in the same

industry. This trademark dispute began in 2007, when Prolacto initiated a proceeding in the

United States Patent and Trademark Office (“USPTO”) seeking cancellation of certain

trademarks registered by PLM. See 2d Am. Compl. (Dkt. No. 40) ¶ 29. In 2011, the Trademark

Trial and Appeal Board (“TTAB”) granted Prolacto’s petition and denied PLM’s later request for

reconsideration of the cancellation. See id. Exs. A–B (Dkt. Nos. 40-1 to 40-2).

       In September 2011, PLM filed a civil action in this Court seeking judicial review of the

TTAB’s cancellation and asserting several other causes of action. See Compl. (Dkt. No. 1).

Despite its success before the USPTO, Prolacto’s operative pleading in this case includes a

cross-appeal of certain TTAB findings adverse to Prolacto. See Answer 2d Am. Compl. &

Countercls. (Dkt. No. 41) at 16–29. Prolacto also asserts seven affirmative counterclaims against

PLM under both federal and D.C. law. See id. at 29–43.

       Discovery in this case has been underway since June 2012. On February 28, 2013, PLM

noticed the deposition of Prolacto pursuant to Federal Rule of Civil Procedure 30(b)(6). See

Mot. Prot. Order Ex. A (Dkt. No. 70-2). PLM’s notice sets Washington, D.C. as the location of

the deposition, but the notice included a cover letter indicating that PLM is “amenable to

working with [Prolacto] if there is a different location in the United States that is more

convenient.” See Liou Decl. Ex. E (Dkt. No. 71-6). Prolacto insisted that the deposition take

place in Mexico City, where Prolacto is headquartered and the deponents reside. See id. Ex. F



                                                  2
(Dkt. No. 71-7). After the parties’ further correspondence failed to resolve the location issue,

Prolacto moved for a protective order requiring that its corporate designees be deposed in

Mexico City or, alternatively, that PLM pay for all of the transportation, lodging, and per diem

expenses associated with a deposition of Prolacto’s designees in the United States. See Mot.

Prot. Order (Dkt. No. 70). PLM opposed the motion. See Opp’n Mot. Prot. Order (Dkt. No. 71).

Prolacto filed a reply brief and supporting declaration, which it seeks to have sealed in part. See

Mot. Seal (Dkt. No. 72). PLM objects to Prolacto’s introduction of new evidence on reply and,

in the alternative, seeks leave to file a sur-reply. See Obj. Evid. Reply (Dkt. No. 75).



               III. PROLACTO’S MOTION FOR A PROTECTIVE ORDER

                                         A. Legal Standard

       A party served with a notice of deposition may move for a protective order pursuant to

Federal Rule of Civil Procedure 26(c):

       A party or any person from whom discovery is sought may move for a protective
       order in the court where the action is pending—or as an alternative on matters
       relating to a deposition, in the court for the district where the deposition will be
       taken. The motion must include a certification that the movant has in good faith
       conferred or attempted to confer with other affected parties in an effort to resolve
       the dispute without court action. The court may, for good cause, issue an order to
       protect a party or person from annoyance, embarrassment, oppression, or undue
       burden or expense . . . .

Fed. R. Civ. P. 26(c)(1). Rule 26(c) empowers the Court to “specify[] terms, including time and

place, for the disclosure or discovery” at issue upon a showing of good cause. Id. at 26(c)(1)(B).

The burden of showing good cause falls upon the party moving for the protective order. See

United States v. Kellogg Brown & Root Servs., Inc., 285 F.R.D. 133, 134 (D.D.C. 2012). “In

considering where the deposition of a corporate agent is to take place, there is a general

presumption that the deposition will occur at the corporation’s principal place of business.


                                                 3
However, this presumption is rebuttable and the Court can focus on several factors to determine

if it would be inappropriate to have the deposition at the foreign defendant corporation’s

principal place of business.” Rundquist v. Vapiano SE, 277 F.R.D. 205, 212 (D.D.C. 2011)

(citations omitted). “The matter of the location of depositions of defendants ultimately is within

the discretion of the Court, and instances of defendants having to appear for depositions at the

place of trial are not unusual.” Fin. Gen. Bankshares, Inc. v. Lance, 80 F.R.D. 22, 23 (D.D.C.

1978).

         When determining whether it is appropriate to override this general presumption, courts

consider the following factors: “location of counsel for both parties; size of defendant

corporation and regularity of executive travel; resolution of discovery disputes by the forum

court; and the nature of the claim and the relationship of the parties.” Nat’l Cmty. Reinv. Coal. v.

NovaStar Fin., Inc., 604 F. Supp. 2d 26, 31 (D.D.C. 2009). These factors are not exhaustive, and

when the proposed deposition involves foreign nationals courts have also considered such factors

as the legal impediments to holding a deposition in the foreign nation and the potential affront to

that nation’s sovereignty. See, e.g., McKesson v. Islamic Republic of Iran, 185 F.R.D. 70, 81

(D.D.C. 1999) (sovereignty); In re Honda Am. Motor Co. Dealership Relations Litig., 168

F.R.D. 535, 540 (D. Md. 1996) (legal impediments).

                                             B. Analysis

         It is uncontested that all lead counsel in this matter are located in California. But

Prolacto argues that the burden of having each party send one attorney to Mexico City is

outweighed by the burden of requiring that multiple witnesses travel to the United States.

Prolacto’s argument ignores the possibility that PLM may wish to apportion the questioning by

deposition topic between two or more of its attorneys. Prolacto provides neither case law nor



                                                   4
logical support for its conclusory assertion that the location of counsel factor “should not be

given much weight with respect to this motion.” See Mem. Supp. Mot. Prot. Order. (Dkt. No.

70-1) at 7. The Court agrees with PLM that this factor weighs in favor of holding the deposition

in California.

       The next factor is the deponent’s size and frequency of executive travel. PLM argues

that, because Prolacto is large enough to have expanded into the United States and sends its

officers to the United States at least occasionally, Prolacto can and should bring its designees

here for deposition. Prolacto counters that it is considerably smaller than PLM. Prolacto frames

this issue in terms of which party is in a better position to bear the costs, but the proper inquiry is

whether Prolacto is unduly burdened by appearing for deposition in the United States. Prolacto

has submitted an approximation of its gross revenues for 2012. See Malfavon Decl. (Dkt. No.

74-1) ¶ 15. But even if the Court were to consider this information, offered for the first time on

reply, it provides an insufficient financial picture to determine the burden a United States

deposition would impose on Prolacto. The record contains no information regarding Prolacto’s

net worth or the operating costs that offset its gross revenues. Prolacto argues that it runs a small

operation, but its insistence that it may need to designate up to seven witnesses to cover the

noticed deposition topics belies that argument. Moreover, PLM has presented evidence that

Prolacto has taken steps to expand its direct operations into the United States and sends its

officers to visit its United States licensees at least a few times per year. See Liou Decl. Ex. B

(Dkt. No. 71-3) at 19; id. Ex. M (Dkt. No. 71-14) at 21; id. Ex. N (Dkt. No. 71-15) at 6–7.




                                                   5
Prolacto’s business is expanding into, and its officers visit, the United States when it suits

Prolacto. So, this factor favors Prolacto’s appearance in the United States.1

       The Court next considers its ability to oversee the deposition. Prolacto argues that the

Court’s ability to supervise the deposition and resolve discovery disputes will not be hindered if

the deposition occurs in Mexico City. PLM disagrees and says that the Court’s jurisdiction will

be weakened if Prolacto’s agents are deposed in Mexico. Because Prolacto is willing to offer its

witnesses voluntarily and hold the deposition under the Federal Rules of Civil Procedure—rather

than under Mexican law pursuant to the Hague Convention—the Court does not find that this

factor favors overriding the general presumption that corporate defendants be deposed at their

principal place of business. Regarding the Court’s ability to supervise the deposition as a

logistical matter, Prolacto is correct (and PLM does not appear to dispute) that the Court would

be able to resolve any discovery dispute telephonically regardless of the one-hour time difference

between Mexico City and Washington, D.C. See also Nat’l Cmty. Reinv. Coal., 604 F. Supp. 2d

at 32 (“Most discovery disputes could be resolved by telephone regardless of the deposition

location (in the unlikely event the Court needed to get involved at all); the convenience of being

within the forum is an insufficient reason to modify the ordinary rule.”).

       The parties are in strong disagreement over the nature of this action and the parties’

relationship. PLM argues that Prolacto originally initiated the cancellation proceeding in the

USPTO and should be viewed as the true “plaintiff” to this action. In support of its proposition

that it is the “defendant” here, Prolacto points out that PLM filed the complaint in this Court.

But in order to preserve its right of judicial review, PLM was required to file the instant lawsuit



       1
        While Prolacto’s reply raises the issue—absent from its opening brief—that not all of its
designees are eligible for United States visas, Prolacto does not contend that it will be unable to
produce at least one witness in the United States on every noticed topic for deposition.
                                                  6
before this Court within sixty days of the TTAB ruling. See 15 U.S.C. § 1071(b).2 Although

PLM is nominally the “plaintiff and counter-defendant” on the case caption, it is Prolacto who

initiated the overall legal dispute here. Moreover, Prolacto has elected to cross-appeal to this

Court for further review of the TTAB’s findings, as well as assert stand-alone causes of action

under federal law and D.C. common law. Thus, Prolacto has availed itself of not only United

States law, but of District of Columbia law. A party that chooses to initiate litigation and invoke

the legal protections of the forum should expect to appear for deposition in that jurisdiction. See

Cobell v. Norton, 213 F.R.D. 43, 47 (D.D.C. 2003) (holding that an elderly named representative

class member failed to present sufficient evidence that his health problems require holding his

deposition in Montana rather than Washington, D.C.); see also Dollar Sys., Inc. v. Tomlin, 102

F.R.D. 93, 94 (M.D. Tenn. 1984) (“[A]ccording to another general rule, the plaintiff will not be

heard to complain about having to appear in the forum-district for the taking of its deposition,

since it selected that forum in the first instance.”). Because Prolacto initiated litigation in the

United States and asserts additional affirmative federal and D.C. causes of action before this

Court, the nature of this action and the relationship of the parties strongly favors a United States

deposition of Prolacto.

       Because Prolacto is a foreign entity, the Court also considers factors relating to the role of

foreign and international law. PLM argues that, should the deposition be required to go forward

in Mexico City, this case will be delayed by legal impediments under the Hague Convention and

Mexican law, including the procedure for obtaining authorization to hold a deposition abroad,

the need to translate case documents and submit them to a Mexican court, and the possibility that



       2
        While 15 U.S.C. § 1071(b)(4) required that civil action be brought in the District of
Columbia when the instant lawsuit was filed, it has since been amended to require that
complaints be filed in the Eastern District of Virginia.
                                                   7
a Mexican court may dismiss deposition questions it finds objectionable or direct its own

questions to the witness. See Mem. Opp’n Mot. Prot. Order (Dkt. No. 71) at 13; Navarro Decl.

(Dkt. No. 71-16) ¶¶ 3–5. This argument is erroneous, as the Hague Convention is a permissive,

not exclusive, discovery tool. See Société Nationale Industrielle Aérospatiale v. U.S. District

Court, 482 U.S. 522, 533–36 (1987). The witnesses in this case are willing to be deposed in

Mexico under United States law, and so a deposition under the Federal Rules of Civil Procedure

is available as a less burdensome alternative to a deposition under Mexican law pursuant to the

Hague Convention. See Fed. R. Civ. P. 28(b); United States ex rel. Barko v. Halliburton Co.,

270 F.R.D. 26, 29 (D.D.C. 2010) (“[T]he instant case does not involve a foreign jurisdiction in

which the taking of a deposition pursuant to the Federal Rules was barred by the law of the

foreign country.”). Compare U.S. Dep’t of State, Mexico Judicial Assistance,

http://travel.state.gov/law/judicial/judicial_677.html (last visited May 1, 2013) (stating that

Mexico, a signatory to the Hague Convention, allows voluntary depositions provided no

compulsion is used), with U.S. Dep’t of State, France Judicial Assistance,

http://travel.state.gov/law/judicial/judicial_647.html (last visited May 1, 2013) (noting that

France requires compliance with the Hague Convention for any deposition of a French citizen or

third country national). PLM has not shown that this alternative violates any Mexican law. The

Court is not convinced that Mexican or international law presents a significant impediment to

holding the deposition abroad in this case. Because the parties have not shown that Mexican law

forbids the taking of depositions pursuant to the Federal Rules of Civil Procedure on Mexican

soil, the “affront to sovereignty” factor is neutral.

        Although the factors do not lean universally in favor of one party, the Court finds that, on

balance, they favor holding the deposition in the United States. This litigation started with



                                                   8
Prolacto’s petition in the USPTO, counsel for all parties are located in California, and Prolacto

has taken advantage of the United States market and its laws. However, due to the location of

counsel and the distance from Mexico City, the Court finds that Southern California—not

Washington, D.C.—may be the most sensible location for the deposition. But the Court leaves it

to the parties, hopefully acting reasonably, to agree to the appropriate location within the United

States.

          Prolacto alternatively seeks an order requiring that PLM pay for the all of its designees’

transportation, lodging, and per diem expenses associated with their deposition in the United

States. As noted above, Prolacto chose to initiate legal action against PLM in the USPTO and

has availed itself of the protections of United States and D.C. law in this Court. Prolacto fails to

cite any case in which a party that asserted affirmative claims—let alone initiated legal action—

in a forum was entitled to reimbursement for deposition-related travel to that forum. Moreover,

because Prolacto can educate its witnesses pursuant to Federal Rule of Civil Procedure 30(b)(6),

it is largely in control of how many witnesses need to be brought to the United States. Therefore,

it is in a position to control its costs and the disruption the depositions will impose on its

business.3 The Court will deny Prolacto’s request for expenses.




          3
         For some unknown reason, Prolacto has refused to identify the witnesses it intends to
designate pursuant to Rule 30(b)(6). Whether or not the Rules require such advance designation,
the Court expects parties to cooperate in order to avoid unnecessary re-deposition of the same
individuals as fact witnesses. See generally Fed. R. Civ. P. 1 (the Rules “should be construed
and administered to secure the just, speedy, and inexpensive determination of every action and
proceeding”). Accordingly, within two weeks of this opinion, Prolacto must identify the
individuals it has designated to testify pursuant to Rule 30(b)(6) and the topics on which each
witness has been designated.
                                                   9
                             IV. PROLACTO’S MOTION TO SEAL

        Prolacto moves to seal portions of its memorandum in reply, portions of the Declaration

of Guillermo Andrade Malfavon, and Exhibit A to the Declaration of Stephen Anderson, on the

basis that these documents include the parties’ sensitive financial data. See Mot. Seal (Dkt. No.

72). Such information is commonly sealed in federal civil litigation. See, e.g., King v. E.F.

Hutton & Co., 117 F.R.D. 2, 12 (D.D.C. 1987) (recommendation of Magistrate Judge to seal

confidential commercial or financial data). However, the Court notes that Prolacto’s motion

does not contain a statement confirming that the parties met and conferred and indicating

whether the motion is opposed. The Court will grant Prolacto’s motion, but reminds the parties

that such a statement is required for future non-dispositive motions in this Court. See Local Civ.

R. 7(m).



              V. PLM’S OBJECTIONS TO EVIDENCE OFFERED IN REPLY

        PLM objects to the additional financial data Prolacto submits in reply and requests, in the

alternative, leave to file a sur-reply. See Obj. Evid. Reply (Dkt. No. 75). Prolacto responds that

it did not have access to PLM’s figures when it filed its motion, but does not even address its

failure to provide Prolacto’s own financial data in support of its opening brief. As the party

seeking a protective order on the basis that PLM’s deposition notice presents an undue financial

burden, Prolacto should have included this evidence with its opening brief. See, e.g., Holiday

CVS, L.L.C. v. Holder, 839 F. Supp. 2d 145, 171 n.16 (D.D.C. 2012) (declining to consider new

evidence and legal arguments raised for the first time on reply). However, because the Court

disposes of Prolacto’s motion in favor of PLM irrespective of whether it formally considers

Prolacto’s reply evidence, the Court will overrule as moot PLM’s objections and deny as moot

its request for leave to file a sur-reply.

                                                10
                                      VI. CONCLUSION

       For the foregoing reasons, the Court denies Prolacto’s motion for a protective order (Dkt.

No. 70), grants Prolacto’s motion to seal (Dkt. No. 72), and overrules as moot PLM’s objections

to evidence (Dkt. No. 75). An order consistent with this Memorandum Opinion is separately and

contemporaneously issued this first day of May, 2013.

       In addition, before bringing a discovery dispute to the Court’s attention, the parties shall

confer in good faith in an attempt to resolve the dispute informally. Going forward, if the parties

are unable to resolve the dispute, they must contact chambers to arrange for a telephonic

conference with the Court. The parties must obtain leave of the Court before filing any motion

relating to a discovery dispute. Any discovery motions that are filed prior to obtaining such

leave may be summarily denied.


                                                             RUDOLPH CONTRERAS
                                                             United States District Judge




                                                11
